Factors Influencing Central Line Infections in Children with Acute Lymphoblastic Leukemia: Results of a Single Institutional Study

Pediatric Blood and Cancer

Volumn 42, Issue 4, 2004, Pages 325-331

  Abbas, Adil A H ^a   Fryer, Christopher J H ^b,e   Paltiel, Charles ^c   Chedid, Fares ^d   Felimban, Sami K ^a   Yousef, Abdulmotalib A ^a   Khattab, Taha M ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b BC CHILDREN S HOSPITAL   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d KING KHALID NATIONAL GUARD HOSPITAL   (Saudi Arabia)

^e CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Childhood leukemia; External venous catheters; Infection; Subcutaneous ports; Timing

Indexed keywords

ANTIBIOTIC AGENT; ASPARAGINASE; CEFTAZIDIME; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VANCOMYCIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE; ARTICLE; CENTRAL VENOUS CATHETERIZATION; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DEVICE INFECTION; FEMALE; HUMAN; IMPLANT; INFECTION; INFECTION RATE; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SAUDI ARABIA; TOTALLY IMPLANTABLE DEVICE;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; EQUIPMENT DESIGN; FEMALE; HUMANS; INFECTION; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 1542357713     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10450     Document Type: Article

References (23)

1. Blacklock HA, Hill RS, Clarke AG, et al. Use of modified subcutaneous right-atrial catheter for venous access in leukemic patients. Lancet 1980;1:993-994.
2. Rackoff WR, Ge J, Sather HN, et al. Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: A report from the Children's Cancer Group. J Pediatr Hematol Oncol 1999;21:260-267.
3. Opie J, Chan K, Rogers P, et al. Implantable intravenous access devices in children. BC Med J 1987;29:274-276.
4. Ross M, Haase GM, Poole MA, et al. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncology patients. Surg Gyn Obstet 1988; 167:141-144.
5. Mirro J, Jr., Rao BN, Kumar M, et al. A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. J Pediatr Surg 1990;25:120-124.
6. Ingram J, Weizman S, Greenberg ML, et al. Complications of indwelling venous access lines in pediatric hematology patients: A prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 1991;13:130-136.
7. Wurzel CL, Halom K, Feldman JG, et al. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child 1988;142:536-540.
8. Shaul DB, Scheer B, Rokhsar S, et al. Risk factors for early infection of central venous catheters in pediatric patients. JAm Coll Surg 1998;186(6):654-658.
9. Johnson PR, Decker MD, Edwards KM, et al. Frequency of Broviac catheter infections in pediatric oncology patients. J Infect Dis 1986;154:570-578.
10. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infections. N Engl J Med 1977;296:1305-1309.
11. Wing EJ, Norden CW, Shadduck RK, et al. Use of quantitatative bacteriologic techniques to diagnose catheter-related sepsis. Arch Intern Med 1979;139:482-483.
12. Barriga FJ, Varas M, Potin M, et al. Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Med Pediatr Oncol 1997;28:196-200.
13. Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial. J Clin Oncol 2000;18:1269-1278.
14. Gorelick MH, Owen WC, Seibel NL, et al. Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatr Infect Dis J 1991;10:506-510.
15. Begala JE, Maher K, Cherry JD. Risk of infection associated with the use of Broviac and Hickman catheters. Am J Infect Control 1982;10:17-23.
16. Decker MD, Edwards KM. Central venous catheter infections. Pediatr Clinics N Am 1988;35:579-612.
17. Garland JS, Henrickson K, Maki DG. The 2002 Hospital Infection Control Practices Advisory Committee Centers for Disease Control and Prevention guideline for prevention of intravascular device-related infection. Pediatrics 2002;110:1009-1013.
18. Young GP, Alexeyeff M, Rusell DM, et al. Catheter sepsis during parenteral nutrition: The safety of long-term Op-Site dressings. J Parenter Enter Nutr 1988;12:365-370.
19. Hoffman KK, Weber DJ, Samsa GP, et al. Transparent polyurethane film as an intravenous catheter dressing: A meta-analysis of the infection risks. JAMA 1992;267:2072-2076.
20. Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: A prospective trial. Pediatr Infect Dis J 1995;14: 510-516.
21. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339-343.
22. Garland JS, Dunne WM, Havens P, et al. Peripheral intravenous catheter complications in critically ill children: A prospective study. Pediatrics 1992;89:1145-1150.
23. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:18-24.